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1 1. Introduction 2 The antimicrobial effects of fatty acids have been well documented. 1 Generally, long 3 chain fatty acids have activity against Gram-positive bacteria while short chain fatty 4 acids are more active against Gram-negative bacteria. Lauric acid (medium chain fatty 5 acid) is regarded as the most active, with reported activity against both Gram-positive 6
and Gram-negative bacteria. 2 Lauric acid and gentamicin combined have been 7 reported to show activity against MRSA. 3 Lauric acid is inexpensive and therefore 8 may be very useful for infection control in hospitals. 9
Esterification of fatty acids with monohydric alcohols such as methanol or ethanol has 10 been shown to reduce their antimicrobial activity. 4 In contrast, esterification of fatty 11 acids to the polyhydric alcohol glycerol increased their effectiveness. 5 One of the 12 most active of these antimicrobial derivatives is monolaurin (Lauricidin®), the 13 glycerol monoester of lauric acid, which is used as a key ingredient of antimicrobial 14 food additives to inhibit the growth of undesirable microorganisms. 6,7 15 More recently, a study has shown that the corresponding ether of monolaurin, 16 dodecylglycerol, had greater potency against Streptococcus faecium than monolaurin 17 itself, albeit depending on the incubation conditions. 8 The greater potency of 18 dodecylglycerol was ascribed to its greater retention by the cell, and its action on 19 specific receptors or enzymes. 20
Another class of fatty acid derivatives which have broad applications in the food 21 industry are carbohydrate fatty acid esters. 9, 10 While they are most commonly 22 employed as surfactants, their antimicrobial properties have been documented. 11 The 23 use of carbohydrate esters is increasingly favoured since they are biodegradable, are 24 configuration with respect to glucopyranoside), the glycoconjugate linkage and the 1 length of fatty acid chain on antimicrobial activity. 2 A quantitative assay for antimicrobial activity was used to allow comparisons between 3 compounds and all were measured relative to the free fatty acids and monolaurin as 4 reference compounds. 5
Enzymatic synthesis of novel sugar fatty acid esters has been widely employed and 6 can be highly regioselective, although for some carbohydrates minor regiomeric 7 isomers may be obtained. For this study, we have developed a chemical route to allow 8 us synthesise a number of pure, regio-defined, monosaccharide mono fatty acid esters 9 (Scheme 1). We have also developed a route to the corresponding ether derivatives 10 (Scheme 2). In order to establish whether a second fatty acid conjugated to a 11 monosaccharide would improve antimicrobial activity, a route was developed to 12 synthesise a di-laurate derivative (Scheme 3). Furthermore, to investigate whether the 13 structure and therefore the synthesis, could be simplified and retain activity, non-14 carbohydrate hydroxylated esters based on a pentaerythritol core were synthesised by 15 a straightforward esterification (Scheme 4). 16
Results and Discussion 17

Synthesis 18
A designed chemical route to obtain mono-ester 19 sugars is shown in Scheme 1 and is based on the following carbohydrate starting 20 materials: 1a methyl α-D-glucopyranoside, 1b methyl β-D-glucopyranoside, 1c methyl 21 α-D-mannopyranoside and 1d methyl α-D-galactopyranoside.
The synthesis 22 commenced with the selective protection of the primary hydroxyl of sugars 1a-d with 23 a triisopropylsilyl (TIPS) group. The silyl derivatives were then fully protected with 24 benzyl groups to give 2a-d. The removal of the TIPS group by tetrabutylammonium 25 fluoride in THF allowed for the esterification of the free 6-OH position with either 1 lauroyl chloride to yield 3a-d or octanoyl chloride to yield 5a. Removal 
Antimicrobial activity of fatty acid derivatives 15
Two non-carbohydrate polyhydroxylated fatty acid ester derivatives, six carbohydrate 16 fatty acid ester derivatives and two carbohydrate long chain alkyl ether derivatives, together with their corresponding polyhydric alcohols, fatty acids and monoglycerides 1 as controls, were tested against a Gram-positive bacteria, Staphylococcus aureus, and 2 a Gram-negative bacteria, Escherichia coli, to assess their antimicrobial activity. The 3 efficacy of the derivatives and controls were compared using Minimum Inhibitory 4
Concentration values (MIC), which was defined as the lowest concentration of 5 compound that showed no increase in cell growth for all the replicates compared to a 6 negative control after 18 hours. 7
The polyhydric alcohols (carbohydrates and pentaerythritol) showed no antimicrobial 8 activity or growth promoting effects for the microorganisms under the conditions used 9
(results not shown). 10 The data in Table 3 show that the monoglycerides monolaurin and monocaprylin, had 1 greater activity compared to the free fatty acids lauric acid and caprylic acid against S. 2 aureus. Of the monoglycerides and free fatty acids tested, monolaurin had the lowest 3 MIC values for S. aureus, with a value of 0.04 mM compared to a value of 0.63 mM 4 for lauric acid. Furthermore, monocaprylin showed MIC values of 2.5 mM against S. 5 aureus compared to the value of 5.0 mM for caprylic acid. With respect to E. coli, 6 monolaurin showed less inhibitory effect than lauric acid with values of 20 mM and 7 10 mM respectively. In contrast, monocaprylin showed activity against E. coli at 8 concentrations of 6.25 mM compared with caprylic acid value of 12.5 mM. 9
All fatty acid derivatives showed greater antimicrobial activity against S. aureus than 10
E. coli. 11
Among the sugar fatty acid esters and the sugar alkyl ethers prepared, methyl 6-O- The di-substituted methyl 4,6-di-O-lauroyl-α-D-glucopyranoside 12a did not show 24 any activity comparable with either the monoglycerides or indeed the mono-substituted sugar derivatives. This was attributed to poor solubility in water, as was 1 the case for the di-substituted non-sugar compound di-lauroyl pentaerythritol 15. In this present study, we have evaluated the effect of polyhydroxylated fatty acid 7 derivatives as inhibitors of a Gram-positive (S. aureus) and a Gram-negative (E. coli) 8 microorganism of concern to the food and healthcare industries. Several of the 9 synthesised compounds have antimicrobial efficacy comparable with commercially 10 available antimicrobials against S. aureus. 11
We studied the effect of carbohydrate versus non-carbohydrate hydrophilic cores 12 (carbohydrate and pentaerythritol laurates), the degree of substitution (monoester and 13 diester), the monosaccharide core (glucopyranoside, mannopyranoside and 14 galactopyranoside), the anomeric configuration (α and β glucopyranoside), the type of 15 fatty acid carbohydrate linkage (ester and ether), and the length of fatty acid chain 16
(lauric and caprylic) on antimicrobial activity. 17
As with the monoglycerides and free fatty acids, all of the fatty acid derivatives that 18 were found to be active showed greater antimicrobial activity against the S. aureus 19 than E. coli. 20
The non-carbohydrate pentaerythritol monoester 14, which has the same number of 21 free hydroxyl groups as the carbohydrate monoester derivatives, showed negligible 22 activity against both microorganisms tested, indicating that the carbohydrate itself 23 could play an important role in the antimicrobial activity of these compounds. 24
The degree of substitution of these derivatives was also shown to be crucial as both 1 the non-sugar pentaerythritol diester 15 and the carbohydrate methyl α-D-2 glucopyranoside diester 12a were much less soluble in water than the monoesters. As 3 a consequence, no antimicrobial activity results for these compounds could be 4 obtained. 5
With regard to the influence of different sugar cores, the results showed that the lauric 6 ester derivative of methyl α-D-mannopyranoside 4c and methyl β-D-glucopyranoside 7 4b, showed higher activity than any other ester derivatives against S. aureus, 8 supporting the observation that the nature of the carbohydrate is involved in the 9 antimicrobial efficacy of the derivatives. This conclusion is consistent with results of 10 an earlier study by Watanabe et al. 15 11 Further evidence for this is noted in the results for the lauric ester anomers of methyl 12 glucopyranoside 4a and 4b. A difference was noted when these compounds were 13 tested against S. aureus with the beta configuration showing higher activity. The 14 lauric ether anomers of methyl glucopyranoside 9a and 9b also showed a marked 15 difference in activity when tested against S. aureus, with the alpha configuration 16
showing a much higher activity. 17
In addition, the difference in activity between the ester and ether conjugates of the 18 same carbohydrate showed that for the methyl α-D-glucopyranoside derivatives, the 19 ether derivative 9a was more active than the ester 4a, however for methyl β-D-20 glucopyranoside, the ester 4b was more active than the ether 9b. These results 21 indicate that, in combination with other factors, the nature of the bond conjugating the 22 fatty acid to the carbohydrate could play some role in antimicrobial activity. 23
The importance of the chain length of the fatty acid ester was investigated using both 24 lauric and caprylic derivatives. The lauric ester derivative 4a showed much higher activity against S. aureus compared to the corresponding caprylic ester derivative 6a. 1 Conversely, the caprylic ester derivative 6a showed higher activity against E. coli, 2 compared with the lauric derivative 4a. This trend was also observed for the 3 monoglyceride controls and is in accordance with general trends observed for medium 4 and short chain fatty acids. 2 5 In conclusion, these results suggest that the nature of the carbohydrate core plays a 6 role in the efficacy of carbohydrate fatty acid derivatives as antimicrobials, and 7 therefore further optimisation may be possible. However, to confirm the trends 8 outlined with respect to the importance of the carbohydrate moiety and the role of the 9 nature of the glycoconjugate bond, further studies are warranted using a wider range 10 of Gram-positive and Gram-negative microorganisms, which would allow for 11 evaluation of potential species and strain effects. FTIR spectra were recorded with a Nicolet FT-IR 5DXB infrared spectrometer, 4 samples were prepared in a KBr matrix. Low resolution mass spectra were measured 5 on a Quatromicro tandem quadropole mass spectrometer.
Methyl
methyl-α-D-galactopyranoside, pentaerythritol, 1-chlorododecane, lauroyl chloride 8 and octanoyl chloride were purchased from Sigma Aldrich. 9
Methyl 2,3,4-tri-O-benzyl-6-O-triisopropylsilyl-α-D-glucopyranoside (2a) 10
A solution of 1a (5 g, 25 mmol) in DMF anhydrous (120 mL) was treated with 11 triisopropylsilyl chloride (15 mL, 75 mmol) and imidazole (5 g, 75 mmol) and 12 allowed to stir at room temperature for 24 h. The crude TIPS protected intermediate 13 was then concentrated in vacuo and dissolved in EtOAc. It was washed with 10% 14 HCl, water, followed by sat. aq. NaHCO 3 , and finally sat. aq. NaCl. It was then dried 15 over anhydrous MgSO 4 , and concentrated under reduced pressure. 23 The crude 16 product was dissolved in DMF anhydrous (50 mL) and cooled to 0 o C. NaH (5 g, 125 17 mmol) was added portion wise, BnBr (9 mL, 75 mmol) was added and the mixture 18 was allowed to warm to room temperature and stir for 24 h. MeOH (50 mL) was 19 added to quench the mixture which was stirred for 1 h. The fully protected sugar was 20 then concentrated in vacuo and dissolved in EtOAc. The solution was washed with 21 water, dried over anhydrous MgSO 4 , and concentrated under diminished pressure. 24 
22
The resulting residue was purified by chromatography (petroleum ether-EtOAc) to 23
give 2a ( Na] + . 10
Methyl 2,3,4-tri-O-benzyl-6-O-triisopropylsilyl-β-D-glucopyranoside (2b) 11
Treatment of 1b (4.5 g, 23.17 mmol) as described for 1a gave 2b ( solution was allowed to warm to room temperature and stir for 1 h. 25 It was then 3 concentrated in vacuo and approximately 1 mmol of the resulting 6-OH residue was 4 dissolved in pyridine anhydrous (25 mL). 4-Dimethylaminopyridine and lauroyl 5 chloride (0.29 mL, 1.22 mmol) were added and the solution was allowed to stir at 6 room temperature for 24 h. 26 aliphatic OCOCH 2 C 10 H 21 ), 1.61 (m, 2H, aliphatic OCOCH 2 CH 2 C 9 H 19 ), 1.28-1. 24 
Methyl 2,3,4-tri-O-benzyl-6-O-lauroyl-β-D-glucopyranoside (3b)
Methyl 2,3,4-tri-O-benzyl-6-O-lauroyl-α-D-mannopyranoside (3c) 17
Treatment of 2c (6.2 g, 10.0 mmol) as described for 2a gave 3c (4.1 g, 64%); [α] D 
Methyl 2,3,4-tri-O-benzyl-6-O-lauroyl-α-D-galactopyranoside (3d) 10
Treatment of 2d (5.7 g, 9.2 mmol) as described for 2a gave 3d 
Methyl 6-O-lauroyl-α-D-glucopyranoside (4a) 3
Compound 3a (0.34 g, 0.2 mmol) was dissolved in EtOH (1 mL) and Pd-C (0.1 g) 4 was added. The mixture was allowed to shake under hydrogen atmosphere of 2 psi 5 until all protecting groups had been removed, as shown by TLC, to yield 4a. The 6 suspension was filtered and concentrated in vacuo. 27 
Methyl 6-O-lauroyl-β-D-glucopyranoside (4b) 18
Treatment of 3b (2.0 g, 3.0 mmol) as described for 3a gave 4b (0.86 g, 75%); [α] D -19 25 .5º ( solution was warmed to room temperature and stirred for 1 h. 25 The mixture was then 10 concentrated in vacuo and the resulting 6-OH residue was dissolved in pyridine 11 anhydrous (100 mL). 4-Dimethylaminopyridine and octanoyl chloride (2.9 mL, 17 12 mmol) was added and the mixture was stirred at room temperature for 24 h. 26 then washed with 10% HCl, water, followed by sat. aq. NaHCO 3 , and finally sat. aq. 23
NaCl, before being dried over anhydrous MgSO 4 , and concentrated under reduced 24 pressure. 23 The TIPS protected crude residue was then split in two and half was dissolved in DMF anhydrous (30 mL) and THF anhydrous (20 mL). This solution 1 was then added dropwise at 0 o C to a suspension of NaH (2.5 g, 62.5 mmol) in DMF 2 anhydrous (10 mL) and THF anhydrous (7 mL), paramethoxybenzyl chloride (17 mL, 3 125 mmol) and tetrabutylammonium iodide (18.5 g, 50 mmol). This was stirred at 4 approximately 10 o C for 30 min and then allowed to warm to room temperature and 5 stir for 24 h. MeOH (50 mL) was added to quench the mixture which was stirred for 6 1 h. The solution was then concentrated under diminished pressure and dissolved in 7
EtOAc. It was washed with water, dried over anhydrous MgSO 4 , and concentrated in 8 vacuo. 28 The resulting residue was purified by chromatography (petroleum ether-9
EtOAc) to give 7a. Compound 7a (4.0 g, 5.5 mmol) was dissolved in THF anhydrous (100 mL) and was 13 cooled to 0 o C. Tetrabutylammonium fluoride (1.4 g, 5.5 mmol) was added and the 14 solution was allowed to warm to room temperature and stir for 1 h. 25 The mixture 15 was then concentrated in vacuo, and the resulting 6-OH residue was dissolved in 16 DMF anhydrous (100 mL). 1-chlorododecane (1.8 mL, 11 mmol) was added and the 17 solution was cooled to 0 o C before NaH (0.11 g, 2.75 mmol) was added portion wise. 18
The mixture was then allowed to warm to room temperature and was stirred for 24 h. 19
MeOH (50 mL) was added to quench the solution which was stirred for 1 h. 29 
Methyl 2,3-di-O-benzyl-4,6-di-O-benzylidene-α-D-glucopyranoside (10a) 6
A solution of 1a (1.0 g, 5.2 mmol), p-toluenesulfonic acid (10 mg) and benzaldehyde 7 dimethylacetal (1.5 mL, 10.3 mmol) in acetonitrile anhydrous (25 mL) was stirred for 8 24 h at room temperature. Trimethylamine (0.5 mL) was added to neutralise the 9 solution which was then stirred for 1 h. The product was filtered off as a white solid, 10 washed with petroleum ether and dried. The benzylidene protected intermediate was 11
then dissolved in DMF anhydrous (15 mL) and the solution was cooled to 0 o C. NaH 12 (0.74 g, 18.4 mmol) was added slowly, followed by benzyl bromide (2.5 mL, 20 13 mmol). The mixture was then warmed to room temperature and stirred over night. 14 MeOH (10 mL) was added to quench the solution which was stirred for a further 1 15 hr. 24 The mixture was then concentrated under diminished pressure and purified by 16 chromatography (petroleum ether-EtOAc) to give 10a. Compound 10a (1.7 g, 3.6 mmol) was dissolved in MeOH (50 mL) and a catalytic 6 amount of TsOH was added. The solution was stirred at room temperature overnight, 7 after which Et 3 N (2 mL) was added to quench the reaction. 31 The mixture was 8 concentrated under diminished pressure and the crude diol residue was dissolved in 9 pyridine anhydrous (70 mL). 4-Dimethylaminopyridine and lauroyl chloride (3.3 mL, 10 14.4 mmol) was added and the reaction was stirred at room temperature for 3 h. 26 BioTek) and effects were monitored by measuring the optical density (OD) at 600 nm 17 for each well every 20 minutes with 20 seconds agitation before each OD 18 measurement. Each experiment was replicated three times. The MIC was defined as 19 the lowest concentration of compound that showed no increase in OD values for all 20 the replicates compared to the negative control after 18 hours. Subtraction of the 21 absorbance of the negative control eliminated interferences due to variation in the 22 media. 23
